Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vivo application of base and prime editing to treat inherited retinal diseases

12 Oct 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Cytomegalovirus and herpesvirus research
Share to Retinal Development and Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36241547
DOI: 10.1016/j.preteyeres.2022.101132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vivo application of base and prime editing to treat inherited retinal diseasesPMID 36241547Read ↗

Base and Prime Editing in the Retina—From Preclinical Research toward Human Clinical TrialsSemantic proximity Read ↗

Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.Semantic proximity Read ↗

Genome editing, a superior therapy for inherited retinal diseasesSemantic proximity Read ↗

Restoration of visual function in adult mice with an inherited retinal disease via adenine base editingSemantic proximity Read ↗

Prime editing: A gene precision editing tool from inception to present.Semantic proximity Read ↗

Precision genome editing in the eye.Semantic proximity Read ↗

In vivo somatic cell base editing and prime editingSemantic proximity Read ↗

Prime Editing for Human Gene Therapy: Where Are We Now?Semantic proximity Read ↗

Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnologySemantic proximity Read ↗

Prime editing: current advances and therapeutic opportunities in human diseases.Semantic proximity Read ↗

Gene Therapy for Retinitis Pigmentosa: Current Challenges and New Progress.Semantic proximity Read ↗

Prime editing enables precise genome editing in mouse liver and retinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.